INTRODUCTION

Since the introduction of the Federal Target
Program "Prevention and Treatment of Arterial Hypertension in the Russian Federation," the number of officially registered hypertensive patients has increased from slightly over 5 million in the year 2000 to almost 11.5 million in 2010 [1] . However, the actual number of hypertensive patients is estimated to be more than four times higher than the official registered number [1, 2] . This high prevalence, coupled with suboptimal diagnosis and treatment, translates into very high levels of cardiovascular (CV) morbidity and mortality, accounting for 57% of all deaths in the country [1] .
Mortality rates in 2010 in Russia from all CV diseases were 805.9 per 100,000 and were 1,009.1 per 100,000 in Yaroslavl region [1] .
Because of this high CV mortality rate and the role of hypertension as the major risk factor for total mortality, our study was conducted with the goal of better understanding the current hypertension treatment practices [3] . 
RESULTS
A total of 1,794 patient diaries (1,525 from GPs; 269 from cardiologists) were collected and analyzed. Among all patients, this was a first visit for hypertension for 8% of patients (termed "primary patients"). Reasons for the present visit for all patients and primary patients are presented in Fig. 1a and 1b, respectively. For all patients, the most common reasons were headache (68%) and planned visit (59%); for primary patients, the most common reasons were headache (62%) and high self-measured home BP (49%).
Physicians' actions for primary patients are presented in Fig. 1c Table 1 . The majority of patients were women, the mean age was 60 years, and half were of working age according to Russian standards (<60 years for men and <55 years for women). The frequencies of risk factors, end organ diseases, and associated clinical conditions are also presented in Table 1 . Table 2 .
The population can be characterized as having a high CV risk profile. Mean BP level was 151/90 mmHg and mean heart rate was 74 bpm.
Goal BP level (<140/90 mmHg; set by the 2010
Russian National Guidelines [4] ) was achieved in 16.8% of all patients ( and ARB losartan (13%; 49.6 mg/day).
Of note, although US and UK guidelines do not include beta blockers as first-line treatment for uncomplicated hypertension [5, 6] , Russian [4, 7, 8] , and European [9, 10] guidelines consider them one of the five major treatment classes for first-line treatment of hypertension.
DISCUSSION
According to the latest reports from the 10-year Actions at the rst patient's visit, % All physician's primary patients (n = 138) GPs' primary patients (n = 89) Cardiologists' primary patients (n = 49) Hypertension Guidelines [7, 8] .
CV mortality, especially mortality from cerebrovascular disease, remains excessively high in Russia, as well as in Yaroslavl region [1] .
As hypertension is considered the most important risk factor for total and CV mortality, The high CV risk profile of the observed population is highly representative of the implementation of a guidelines-based approach that highlights the necessity for effective combinations in effective doses to achieve BP control, and a need to advocate for patients' adherence to therapy, will improve control rates and decrease morbidity and mortality due to heart diseases and cerebrovascular diseases.
Limitations
Our survey has an obvious limitation of having a one-time, cross-sectional design. Physicians to Russian guidelines [4] and is not recommended according to European guidelines [9, 10] . In addition, the most frequently used diuretic in our survey was indapamide at mean doses >2 mg, which is rarely found in single-pill combinations.
Despite the availability of comprehensive 
